JP2023522066A5 - - Google Patents
Info
- Publication number
- JP2023522066A5 JP2023522066A5 JP2022563013A JP2022563013A JP2023522066A5 JP 2023522066 A5 JP2023522066 A5 JP 2023522066A5 JP 2022563013 A JP2022563013 A JP 2022563013A JP 2022563013 A JP2022563013 A JP 2022563013A JP 2023522066 A5 JP2023522066 A5 JP 2023522066A5
- Authority
- JP
- Japan
- Prior art keywords
- stroke
- individual
- lvo
- amount
- biomarker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2005632.1 | 2020-04-17 | ||
| GB2005632.1A GB2594094A (en) | 2020-04-17 | 2020-04-17 | Method for diagnosing stroke caused by large vessel occlusion |
| PCT/GB2020/053340 WO2021209732A1 (en) | 2020-04-17 | 2020-12-22 | D-dimer, glial fibrillary acidic protein (gfap), osteoprotegerin (opg) and osteopontin (opn) as biomarkers for stroke caused by large vessel occlusion |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522066A JP2023522066A (ja) | 2023-05-26 |
| JP2023522066A5 true JP2023522066A5 (cg-RX-API-DMAC7.html) | 2024-01-04 |
| JP7711092B2 JP7711092B2 (ja) | 2025-07-22 |
Family
ID=70860060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022563013A Active JP7711092B2 (ja) | 2020-04-17 | 2020-12-22 | 大血管閉塞により引き起こされる卒中についてのバイオマーカーとしてのｄ－ダイマー、グリア線維酸性タンパク質（ｇｆａｐ）、オステオプロテジェリン（ｏｐｇ）及びオステオポンチン（ｏｐｎ） |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11726100B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4136458A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7711092B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230004594A (cg-RX-API-DMAC7.html) |
| GB (3) | GB2594094A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021209732A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220381794A1 (en) * | 2019-05-16 | 2022-12-01 | Fundació Hospital Universitari Vall D'hebron - Institut De Recerca | Method for selecting a patient for a reperfusion therapy |
| GB2594094A (en) * | 2020-04-17 | 2021-10-20 | Pockit Diagnostics Ltd | Method for diagnosing stroke caused by large vessel occlusion |
| US20240192231A1 (en) * | 2021-04-15 | 2024-06-13 | Fundació Hospital Universitari Vall D'hebron - Institut De Recerca | Markers for the diagnosis of large vessel occlusion |
| KR20250004423A (ko) * | 2023-06-29 | 2025-01-08 | 프리시젼바이오 주식회사 | 허혈성 뇌졸증 진단용 분석장치 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5660985A (en) | 1990-06-11 | 1997-08-26 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands containing modified nucleotides |
| US5707796A (en) | 1990-06-11 | 1998-01-13 | Nexstar Pharmaceuticals, Inc. | Method for selecting nucleic acids on the basis of structure |
| US5567588A (en) | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
| US5496938A (en) | 1990-06-11 | 1996-03-05 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to HIV-RT and HIV-1 rev |
| US6011020A (en) | 1990-06-11 | 2000-01-04 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand complexes |
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| US5683867A (en) | 1990-06-11 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: blended SELEX |
| US5637459A (en) | 1990-06-11 | 1997-06-10 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chimeric selex |
| ES2259800T3 (es) | 1990-06-11 | 2006-10-16 | Gilead Sciences, Inc. | Procedimientos de uso de ligandos de acido nucleico. |
| EP1058736A1 (en) * | 1998-02-24 | 2000-12-13 | University Of Notre Dame Du Lac | Use of succinate as a diagnostic tool |
| US7392140B2 (en) | 2003-09-23 | 2008-06-24 | Prediction Sciences, Llc | Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof |
| WO2012009567A2 (en) * | 2010-07-15 | 2012-01-19 | The Regents Of The University Of California | Biomarkers for diagnosis of stroke and its causes |
| CN106011233A (zh) * | 2010-08-13 | 2016-10-12 | 莫尔豪斯医学院 | 中风的生物标记 |
| GB201309928D0 (en) | 2013-06-04 | 2013-07-17 | Randox Lab Ltd | Method |
| EP3029466A1 (en) * | 2014-12-03 | 2016-06-08 | Fundació Hospital Universitari Vall d' Hebron - Institut de Recerca | Methods for differentiating ischemic stroke from hemorrhagic stroke |
| US11774457B2 (en) * | 2018-07-09 | 2023-10-03 | Wright State University | Identification and analysis of protein biomarkers |
| US20220381794A1 (en) * | 2019-05-16 | 2022-12-01 | Fundació Hospital Universitari Vall D'hebron - Institut De Recerca | Method for selecting a patient for a reperfusion therapy |
| GB2594094A (en) | 2020-04-17 | 2021-10-20 | Pockit Diagnostics Ltd | Method for diagnosing stroke caused by large vessel occlusion |
-
2020
- 2020-04-17 GB GB2005632.1A patent/GB2594094A/en not_active Withdrawn
- 2020-12-22 WO PCT/GB2020/053340 patent/WO2021209732A1/en not_active Ceased
- 2020-12-22 GB GB2407291.0A patent/GB2627388B/en active Active
- 2020-12-22 GB GB2200967.4A patent/GB2600844B/en active Active
- 2020-12-22 JP JP2022563013A patent/JP7711092B2/ja active Active
- 2020-12-22 KR KR1020227039385A patent/KR20230004594A/ko active Pending
- 2020-12-22 EP EP20838261.4A patent/EP4136458A1/en active Pending
-
2022
- 2022-09-22 US US17/934,454 patent/US11726100B2/en active Active
-
2023
- 2023-06-01 US US18/327,243 patent/US12584925B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023522066A5 (cg-RX-API-DMAC7.html) | ||
| Fan et al. | Diagnosing sepsis–The role of laboratory medicine | |
| US12085565B2 (en) | SNTF is a blood biomarker for the diagnosis and prognosis of sports-related concussion | |
| EP2300829B1 (en) | New biomarker for diagnosis, prediction and/or prognosis of sepsis and uses thereof | |
| GB2600844A (en) | D-dimer, glial fibrillary acidic protein (GFAP) osteoprotegerin (OPG) and osteopontin (OPN) as biomarkers for stroke caused by large vessel occlusion | |
| JPWO2022071601A5 (cg-RX-API-DMAC7.html) | ||
| US20130210667A1 (en) | Biomarkers for Predicting Kidney and Glomerular Pathologies | |
| Bustamante et al. | Sepsis biomarkers reprofiling to predict stroke-associated infections | |
| CN110702917A (zh) | 血清淀粉样蛋白p在制备抑郁症诊断治疗相关产品的用途 | |
| EP3864407A1 (en) | Biomarker of chronic kidney disease in liver transplant recipients | |
| TWI655433B (zh) | 川崎氏症之診斷與治療 | |
| KR102328932B1 (ko) | 신장이식 후 항체 매개성 거부반응의 진단 또는 예측을 위한 소변 엑소좀 바이오마커 | |
| JP2021523375A5 (cg-RX-API-DMAC7.html) | ||
| JP7162104B2 (ja) | 糖尿病性腎症の早期病態の特異的な診断を可能とする検査方法 | |
| CN106461674A (zh) | 一种用于诊断结核性脑膜炎的方法 | |
| CN110988351B (zh) | 血管细胞黏附分子在制备抑郁症诊断治疗相关产品的用途 | |
| JP6252949B2 (ja) | 統合失調症マーカーセット及びその利用 | |
| JP7497851B2 (ja) | アルツハイマー病診断のためのアッセイ | |
| EP3682236A1 (en) | Proadrenomedullin as indicator for renal replacement therapy in critically ill patients | |
| JP2022550825A (ja) | 尿サンプル中において結核の診断を行なうための方法 | |
| US8394639B2 (en) | Biomarkers for renal disease | |
| WO2007148720A1 (ja) | ネフローゼ症候群の疾患関連たんぱく質およびその使用 | |
| WO2025167800A1 (en) | Blood proteomic markers for stroke and methods thereof | |
| US20260043813A1 (en) | Chronic kidney disease detection | |
| JP2020502541A5 (cg-RX-API-DMAC7.html) |